Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment

已完结 10 由 SDRD 发布于 2026/3/15 14:54:55

DOI:10.1021/acs.jmedchem.5c01120
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1021/acs.jmedchem.5c01120

American Chemical Society (ACS)

Abstract：Parallel activation of the calcitonin receptor (CTR) and amylin receptor (AMYR) is considered a more effective weight-loss strategy. Although the novel dual amylin and calcitonin receptor ag

应助信息

1天前

yan80

ebd8103c203c11f19d9534735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/3/15 14:54:55 未找到该文献，机器人已退出，请等待人工下载

2026/3/15 14:54:55 Book学术AI机器人收到请求，开始寻找文献

2026/3/15 14:54:55 已向机器人发送请求

1天前

SDRD 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Engineering of an Ultralong-Acting and Nonaggregating Dual Amylin and Calcitonin Receptor Agonist with Durable Efficacy in Obesity and Diabetes